Table 1 |
|
|
Demographic and disease-related variables in 163 female patients with systemic lupus erythematosus |
|
|
Demographic variables |
Value |
|
|
|
|
Patient age, years |
47 (20 to 82) |
|
Weight, kg |
66 (42 to 99) |
|
Height, cm |
166 (145 to 182) |
|
Body mass index, kg/m2 |
24.2 (17.2 to 37.2) |
|
Menopausal status |
|
|
Premenopausal, n (%) |
72 (44) |
|
Disease variables |
|
|
Disease duration, years |
11 (1 to 41) |
|
SLEDAI-2K |
5 (0 to 31) |
|
SLICC/ACR Damage Index |
2 (0 to 11) |
|
Kidney affection ever by SLE, n (%) |
40 (25) |
|
S-creatinine, μmol/L |
87 (49 to 291) |
|
Glomerular filtration rate, mL/minute |
74 (22 to 172) |
|
Proteinuria, >3.5 g/24 hours, n (%) |
9 (6) |
|
End-stage kidney disease, n (%) |
1 (0.6) |
|
Hemoglobin, g/L |
131 (75 to 158) |
|
Erythrocyte sedimentation rate, mm/hour |
25 (2 to 125) |
|
C-reactive protein, mg/L |
5 (3 to 100) |
|
Cholesterol, mmol/L |
5.4 (2.4 to 9.3) |
|
High-density lipoprotein, mmol/L |
1.6 (0.5 to 2.8) |
|
Low-density lipoprotein, mmol/L |
3.1 (<0.1 to 6.3) |
|
Triglycerides, mmol/L |
1.2 (0.3 to 6.0) |
|
Albumin, g/L |
40 (11 to 53) |
|
IgG, g/L |
13.5 (5 to 28) |
|
IgA, g/L |
2.5 (0.07 to 11) |
|
IgM, g/L |
1.0 (0.05 to 4.6) |
|
C3, g/L |
0.93 (0.28 to 1.68) |
|
C4, g/L |
0.14 (0.02 to 0.28) |
|
Tumor necrosis factor-alpha, pg/mL |
2.16 (0.40 to 36.96) |
|
Interleukin-1β, pg/mL |
0.47 (0.0 to 9.65) |
|
Interleukin-6, pg/mL |
9.67 (2.81 to 119.0) |
|
sIL-6R, ng/mL |
48.87 (11.56 to 107.15) |
|
Glucocortocosteroid user, n (%) |
85 (52) |
|
Glucocorticosteroid dose, mg |
5 (2.5 to 35) |
|
BMD lumbal spine, g/cm2, mean (SD) |
1.12 (0.18) |
|
BMD total hip, g/cm2, mean (SD) |
0.92 (0.15) |
|
BMD femur neck, g/cm2, mean (SD) |
0.89 (0.15) |
|
BMD radius total, g/cm2, mean (SD) |
0.50 (0.08) |
|
Number of vertebral fractures per patient |
0 (0 to 11) |
|
ICTP, μg/L |
3.59 (0.9 to 16.38) |
|
PINP, μg/L |
43.0 (9.1 to 177.94) |
|
|
|
|
Values are presented as median (and range) unless indicated otherwise. BMD, bone mineral density; ICTP, C-terminal telopeptide of type I collagen; Ig, immunoglobulin; PINP, N-terminal propeptide of type I procollagen; SD, standard deviation; sIL-6R, soluble interleukin-6 receptor; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLICC/ACR, Systemic Lupus International Collaborative Clinics/American College of Rheumatology. |
|
|
Almehed et al. Arthritis Research & Therapy 2008 10:R15 doi:10.1186/ar2366 |
|
